Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Regeneron Pharmaceuticals the Perfect Stock?
Motley Fool
Thursday, June 9, 2011 - 10:47pm
tags:
Regeneron
PDL BioPharma cuts 2Q revenue outlook due to error
Yahoo/AP
Thursday, June 9, 2011 - 7:47pm
tags:
PDL Biopharma, earnings, guidance
It's a Numbers Game With Vertex
Motley Fool
Thursday, June 9, 2011 - 7:44pm
tags:
Vertex Pharmaceuticals, CF, cystic fibrosis, VX-770
Abbott releases early results of Parkinson's study
Yahoo/AP
Thursday, June 9, 2011 - 7:31pm
tags:
Abbott Laboratories, Parkinson's Disease
Merck, Glaxo Drugs Add Warnings About Prostate Cancer Risk
Bloomberg
Thursday, June 9, 2011 - 7:30pm
tags:
enlarged prostate, Merck, GSK, prostate cancer, Proscar, Propecia, Adovart, Jalyn
Selecta teams with diabetes foundation on Type 1 vaccine
Fierce Biotech
Thursday, June 9, 2011 - 11:35am
tags:
vaccines, type 1 diabetes, Selecta
5-Star Stocks Poised to Pop: Bristol-Myers
Motley Fool
Thursday, June 9, 2011 - 11:33am
tags:
Bristol-Myers Squibb
Keryx Biopharmaceuticals vs. AEterna Zentaris
Seeking Alpha
Thursday, June 9, 2011 - 10:17am
tags:
Aeterna Zentaris, Keryx, perifosine, colorectal cancer, Multiple Myeloma
Vertex's promising CF drug combo clears first hurdle in Ph2
Fierce Biotech
Thursday, June 9, 2011 - 9:20am
tags:
CF, cystic fibrosis, Vertex Pharmaceuticals, VX-770
Pay-for-Delay Drug Deals Said to Be Target for Rule at FTC
Bloomberg
Thursday, June 9, 2011 - 9:19am
tags:
FTC, pay-for-delay
Novartis vaccine shields against meningitis cause
Reuters
Thursday, June 9, 2011 - 8:35am
tags:
Novartis, vaccines, meningitis, Bexsero, MenB
FDA postpones ruling on generic Copaxone
Globes, Israel
Thursday, June 9, 2011 - 8:06am
tags:
FDA, generics, Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis
Validus Pharmaceuticals Deploys Veeva iRep to US Salesforce
SunHerald, MS
Thursday, June 9, 2011 - 8:04am
tags:
drug reps, iRep, iPad, Validus
Seattle Genetics and Astellas start development of second experimental cancer drug
Yahoo/AP
Thursday, June 9, 2011 - 8:02am
tags:
Seattle Genetics, Astellas, cancer
Yes, There Will Be More Layoffs at Pfizer, as These Numbers Show
BNET Pharma
Wednesday, June 8, 2011 - 6:51pm
tags:
Pfizer, layoffs
With Cancer Vaccines in Play, Will Investors Continue to Buy-In?
Seeking Alpha
Wednesday, June 8, 2011 - 6:50pm
tags:
cancer, vaccines, investors, BioSante, Northwest Biotherapeutics, ImmunoCellular
Pfizer trying new twist on academic collaborations
Yahoo/AP
Wednesday, June 8, 2011 - 6:48pm
tags:
Pfizer, R&D
District court denies preliminary injunction against drugmaker Eli Lilly in Amylin litigation
Yahoo/AP
Wednesday, June 8, 2011 - 6:48pm
tags:
Eli Lilly, Amylin, diabetes
FDA adds warning about muscle injury to Zocor
Yahoo/AP
Wednesday, June 8, 2011 - 6:46pm
tags:
FDA, warnings, statins, Zocor, Merck, Abbott Laboratories, Simcor
Impax drops 11% on downgrade
Marketwatch
Wednesday, June 8, 2011 - 10:48am
tags:
downgrades, Impax

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.